IL314629A - Peptide inhibitors of the interleukin-23 receptor and pharmaceutical preparations thereof - Google Patents

Peptide inhibitors of the interleukin-23 receptor and pharmaceutical preparations thereof

Info

Publication number
IL314629A
IL314629A IL314629A IL31462924A IL314629A IL 314629 A IL314629 A IL 314629A IL 314629 A IL314629 A IL 314629A IL 31462924 A IL31462924 A IL 31462924A IL 314629 A IL314629 A IL 314629A
Authority
IL
Israel
Prior art keywords
interleukin
receptor
pharmaceutical compositions
peptide inhibitors
peptide
Prior art date
Application number
IL314629A
Other languages
English (en)
Hebrew (he)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL314629A publication Critical patent/IL314629A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL314629A 2022-02-01 2023-01-31 Peptide inhibitors of the interleukin-23 receptor and pharmaceutical preparations thereof IL314629A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263305631P 2022-02-01 2022-02-01
PCT/US2023/061651 WO2023150500A1 (en) 2022-02-01 2023-01-31 Peptide inhibitors of interleukin-23 receptor and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
IL314629A true IL314629A (en) 2024-09-01

Family

ID=85556753

Family Applications (1)

Application Number Title Priority Date Filing Date
IL314629A IL314629A (en) 2022-02-01 2023-01-31 Peptide inhibitors of the interleukin-23 receptor and pharmaceutical preparations thereof

Country Status (13)

Country Link
EP (1) EP4472999A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025506374A (cg-RX-API-DMAC7.html)
KR (1) KR20240137102A (cg-RX-API-DMAC7.html)
CN (1) CN118829647A (cg-RX-API-DMAC7.html)
AU (1) AU2023215245A1 (cg-RX-API-DMAC7.html)
CA (1) CA3250172A1 (cg-RX-API-DMAC7.html)
CL (1) CL2024002263A1 (cg-RX-API-DMAC7.html)
IL (1) IL314629A (cg-RX-API-DMAC7.html)
MX (1) MX2024009477A (cg-RX-API-DMAC7.html)
PE (1) PE20241895A1 (cg-RX-API-DMAC7.html)
TW (1) TW202342496A (cg-RX-API-DMAC7.html)
UY (1) UY40135A (cg-RX-API-DMAC7.html)
WO (1) WO2023150500A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250139359A (ko) 2023-01-31 2025-09-23 얀센 파마슈티카 엔브이 인터류킨-23 수용체의 결정질 펩티드 억제제의 제조 방법
EP4780453A1 (en) * 2023-09-21 2026-07-29 Janssen Pharmaceutica NV Interleukin-23 receptor antagonist for use in the treatment of ulcerative colitis
WO2025151385A1 (en) * 2024-01-08 2025-07-17 Janssen Pharmaceutica Nv Peptide inhibitors of interleukin-23 receptor and uses thereof
WO2025163534A1 (en) * 2024-01-31 2025-08-07 Janssen Pharmaceutica Nv Crystal form of a peptide inhibitor of interleukin-23 receptor
WO2025243217A1 (en) * 2024-05-22 2025-11-27 Janssen Pharmaceutica Nv Crystal forms of peptide molecules
WO2026106852A1 (en) * 2024-11-15 2026-05-21 Janssen Pharmaceutica Nv Methods of using interleukin-23 receptor antagonists
WO2026114760A1 (en) * 2024-11-29 2026-06-04 Zealand Pharma A/S Peptide inhibitors of interleukin-23 receptor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8946150B2 (en) 2011-06-14 2015-02-03 Medical Diagnostic Laboratories, LLC. Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
SMT202500254T1 (it) 2020-01-15 2025-09-12 Janssen Biotech Inc Inibitori peptidici del recettore dell'interleuchina-23 e loro uso per trattare malattie infiammatorie

Also Published As

Publication number Publication date
UY40135A (es) 2023-08-31
KR20240137102A (ko) 2024-09-19
WO2023150500A1 (en) 2023-08-10
CN118829647A (zh) 2024-10-22
AU2023215245A1 (en) 2024-09-19
MX2024009477A (es) 2024-11-08
TW202342496A (zh) 2023-11-01
PE20241895A1 (es) 2024-09-19
CL2024002263A1 (es) 2025-02-07
EP4472999A1 (en) 2024-12-11
CA3250172A1 (en) 2023-08-10
JP2025506374A (ja) 2025-03-11

Similar Documents

Publication Publication Date Title
AU2021383828A9 (en) Compositions of peptide inhibitors of interleukin-23 receptor
EP4247403A4 (en) COMPOSITIONS OF PEPTIDE INHIBITORS OF THE INTERLEUKIN-23 RECEPTOR
IL310061A (en) Peptide inhibitors linked to fatty residues of the interleukin-23 receptor
CA3304401A1 (en) Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
EP4370531A4 (en) PEPTIDE INHIBITORS OF THE INTERLEUKIN-23 RECEPTOR
IL289628A (en) Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
MX2024000761A (es) Inhibidores peptidicos biciclicos del receptor de interleucina-23.
IL316049A (en) Musuntuzumab pharmaceutical preparations and methods of use
IL316170A (en) Pharmaceutical compositions of therapeutic proteins and methods of use
IL309447A (en) Pharmaceutical preparations of epidermal growth factor receptor inhibitor
IL325596A (en) Pharmaceutical preparations for NEK7 kinase inhibitors
IL312884A (en) Peptide conjugates of peptide tubulin inhibitors as therapy
MX2025008922A (es) Metodos para preparar inhibidores peptidicos cristalinos del receptor de interleucina-23
IN202221071152A (en) Extended-release pharmaceutical compositions of dydrogestrone
IL327134A (en) Topical formulations and uses of PAI-1 inhibitors
HK40101100A (en) Compositions of peptide inhibitors of interleukin-23 receptor
HK40129252A (en) Preparation of peptide inhibitor of interleukin-23 receptor and use thereof
IL325960A (en) An orodispersible pharmaceutical solid dosage form of safinamide
CA3293174A1 (en) Peptide inhibitors of interleukin-23 receptor
CA3293116A1 (en) Peptide inhibitors of interleukin-23 receptor
CA3279774A1 (en) Peptide inhibitors of interleukin-23 receptor
CA3279768A1 (en) Peptide inhibitors of interleukin-23 receptor
HK40117623A (en) Peptide inhibitors of interleukin-23 receptor
EP4213876A4 (en) PHARMACEUTICAL COMPOSITIONS OF NICLOSAMIDE AND A PROTEIN
CA3279924A1 (en) Polycyclic peptide inhibitors of interleukin-23 receptor